Capital Advisors Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Capital Advisors Wealth Management, LLC
- $691 Million
- Q4 2025
A detailed history of Capital Advisors Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Advisors Wealth Management, LLC holds 3,224 shares of GILD stock, worth $400,066. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,224
Previous 3,209
0.47%
Holding current value
$400,066
Previous $356,000
12.36%
% of portfolio
0.06%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,399Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...